Treatment for rare childhood brain tumours
The NHS is set to roll out the first ever targeted treatment for brain tumours in children and young people in England, which can be taken at home and has been shown to significantly slow the progression of the disease, allowing them a better quality of life for longer. Dabrafenib with trametinib has been found to stop the disease progressing for more than three times as long as standard chemotherapy for children with low-grade gliomas that have a specific genetic mutation, while helping many be spared the harsh side effects that can come with chemotherapy.